List of Figures:
Figure 5-1: Number of Clinical Trials (2006-2012)
Figure 5-2: Share of Study Type in Clinical Trials (2010)
Figure 5-3: Structure of Clinical Trial Market by Study Type (%), 2010
Figure 5-4: Number of Clinical Trials by Phase (2009 & 2010)
Figure 5-5: Clinical Trials by Therapy Area (%), Q3 2010
Figure 5-6: Share of International Sponsors in Clinical Trials by Phase (2010)
Figure 8-1: Population Breakup by Age Group (%), 2010
Figure 8-2: Share of Population and Clinical Trials by Region
Figure 8-3: Leading Causes of Death (%), 2005 & 2030
Figure 8-4: Share of Patients Recruitment by Study Phase (Q3 2010)
List of Tables:
Table 5-1: Number of Clinical Trials by Top Four Sponsors (2010)
Table 5-2: Number of Clinical Trials by Top Five International Study Sponsors (2010)
Table 5-3: Number of Clinical Trials by Top Russian Study Sponsors (2010)
Table 7-1: Lab Fees Comparison with UK and US (US$)
Table 7-2: Fees Charged by Local CROs in Comparison to International CROs (US$/Hour)
Table 7-3: Timelines Monitoring of Clinical Trials (Days), 2007-2009
Table 8-1: Top Ten Russian Regions by Number of Investigative Site
Table 8-2: Patient Recruitment Rate in Top Five Therapeutic Areas
Table 8-3: Healthcare Workforce Analysis
Table 8-4: Healthcare Infrastructure Analysis
Table 9-1: Quintiles - Strengths & Weaknesses
Table 9-2: PSI Co Ltd - Strengths & Weaknesses
Table 9-3: Clinstar - Strengths & Weaknesses
Table 9-4: Parexel - Strengths & Weaknesses
Table 9-5: ICON - Strengths & Weaknesses
